Pay in 4 interest-free payments of $7.43 Learn more
Ships within 48 hours · Estimated delivery Aug 28 - Sep 2
Elfatih Patients can finally be treated with foreign drug innovations
What the trials showed In the phase 3 programme, the combined response of HDV RNA suppression with ALT normalisation was reached by roughly half of treated patients, and undetectable HDV RNA climbed steadily across 48, 96 and 144 weeks of continued therapy
Testing gives us a clearer picture so we can support you more precisely
A physician evaluation is required before treatment.
US$ 28.00
US$ 25.09
US$ 23.31
US$ 29.74
